MedTrace Logo

EPOCH-Economics and Patient Outcomes in China in Haemophilia

NCT07454239 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-03-06

No results posted yet for this study

Summary

The overarching goal of the EPOCH project is to:

* Support a broad and robust needs assessment in the haemophilia space in China
* Measure the variability in the needs and care provision
* Generate outcome data (health economic outcomes and supporting clinical and PRO data) to enable measuring the impact of different treatment modalities and different levels of treatment access PRIMARY OBJECTIVES
* Determine the burden of haemophilia in China, and the determinants of its variability
* Determine the costs of haemophilia care in China, and the determinants of its variability SECONDARY OBJECTIVES
* Measure treatment patterns and their variability
* Measure levels of access to care
* Estimate the impact of haemophilia and its treatment of patients reported outcomes
* Understand consistency of care by centres/geography/demographics

Conditions

Sponsors & Collaborators

  • EPOCH Study, Ltd.

    collaborator UNKNOWN

  • Institute of Hematology & Blood Diseases Hospital, China

    lead OTHER

Eligibility

Min Age
12 Minutes
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-14
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07454239 on ClinicalTrials.gov